Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Matthew J. Iott"'
Publikováno v:
Rare Tumors, Vol 6, Iss 1 (2014)
Angiosarcoma of the seminal vesicle is an extremely rare malignancy, with few published case reports in the literature. We present a case of primary angiosarcoma of the seminal vesicle in a 45-year-old male who was treated with multimodality therapy,
Externí odkaz:
https://doaj.org/article/74808066c0b34f6d8f01c59b91b57d6d
Publikováno v:
Rare Tumors, Vol 5, Iss 1, Pp e7-e7 (2013)
In the English literature, only 9 cases of adenocarcinoma of the gallbladder with cutaneous metastasis have been reported so far. One case of multiple cutaneous metastases along with deposits in the breast tissue has been reported. We present a case
Externí odkaz:
https://doaj.org/article/1c21906907a04f67a01cfc16eaec9768
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Table 1. PSA progression by number of sites treated. 1Kaplan-Meier method; 2Cox model; 3Logrank test; 4Wald Chi-Square test.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435496c52206d4162494014aa5efdeaa
https://doi.org/10.1158/1078-0432.22484216
https://doi.org/10.1158/1078-0432.22484216
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Figure 2. Flow cytometry gating strategies. (A) Flow cytometry gating strategies of central memory (TCM), effector memory (TEM), effector (TEF), and naïve (TN) T-cells populations. (B) Flow cytometry gating strategies of tumor reactive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69aab2adb4778ae7d147b8f04e57e5df
https://doi.org/10.1158/1078-0432.22484222.v1
https://doi.org/10.1158/1078-0432.22484222.v1
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Figure 1. PSA and distant progression by number of radiation-treated sites. (A) PSA progression by number of sites treated. (B) Distant radiographic progression by number of sites treated.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e12a24bdfd2a5cc529eca9b68e0d60b0
https://doi.org/10.1158/1078-0432.22484225.v1
https://doi.org/10.1158/1078-0432.22484225.v1
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Figure 3. Changes in CD8+CD11ahigh populations from baseline to days 1, 7, and 14.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a7679f2dd4ea6a7f2298f51a14f62b
https://doi.org/10.1158/1078-0432.22484219
https://doi.org/10.1158/1078-0432.22484219
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Purpose:Outcomes for resistant metastatic castration-resistant prostate cancer (CRPC) are poor. Stereotactic ablative radiotherapy (SABR) induces antitumor immunity in clinical and preclinical studies, but immunologic biomarkers are lacking.Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18054fd97430b2ff2ddcf9a52bc6cdae
https://doi.org/10.1158/1078-0432.c.6531356
https://doi.org/10.1158/1078-0432.c.6531356
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Table 3. Baseline TTR and changes after SBRT predict outcomes in oligometastatic CRPC. Median event-free survival survival (in months) and hazard ratio for each outcome and group is given, stratified by baseline TTR levels (left) or cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e76c3294f4aff55ec03320907158306
https://doi.org/10.1158/1078-0432.22484210.v1
https://doi.org/10.1158/1078-0432.22484210.v1
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Table 2. Distant radiographic progression by number of sites treated. 1Kaplan-Meier method; 2Cox model; 3Logrank test; 4Wald Chi-Square test.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ad91d8a21f9fedad02576c0f8a521e8
https://doi.org/10.1158/1078-0432.22484213
https://doi.org/10.1158/1078-0432.22484213
Autor:
Jacob J. Orme, C. Richard Choo, Val J. Lowe, Matthew J. Iott, Michael S. Bold, Brian A. Costello, Mark A. Nathan, Henan Zhang, Haidong Dong, Thomas M. Pisansky, Erik J. Tryggestad, J. Fernando Quevedo, Eugene D. Kwon, Debra H. Brinkmann, William S. Harmsen, Kenneth R. Olivier, Lance C. Pagliaro, Brian J. Davis, Sean S. Park, F. Abraha, Fabrice Lucien, Geoffrey B. Johnson, B.J. Stish
Publikováno v:
Clin Cancer Res
Purpose: Outcomes for resistant metastatic castration-resistant prostate cancer (CRPC) are poor. Stereotactic ablative radiotherapy (SABR) induces antitumor immunity in clinical and preclinical studies, but immunologic biomarkers are lacking. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e603c86f7a18480ea887972a21dc48b
https://europepmc.org/articles/PMC8639778/
https://europepmc.org/articles/PMC8639778/